Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 5, May 2018, Pages 311-373
 
MONOGRAPHS
 
  
 Erenumab.
Human monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, Prevention of episodic and chronic migraine.
Silberstein, S., Xu, C., Dammerman, R., Mikol, D.D.
Drugs Fut 2018, 43(5): 311
Summary | Full Text: PDF 
 
  
  
 NKTR-214.
PEGylated engineered interleukin-2 (IL-2), CD122-biased immunostimulatory cytokine, Cancer immunotherapy.
Rogers, S.C., Shah, H., Yin, M., Folefac, E., Lee, R., Verschraegen, C.
Drugs Fut 2018, 43(5): 323
Summary | Full Text: PDF 
 
  
  
 Risankizumab.
Anti-IL-23p19 monoclonal antibody, Treatment of psoriasis, Treatment of inflammatory bowel disease, Treatment of asthma.
Moro, L.
Drugs Fut 2018, 43(5): 331
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLES
 
  
 Diabetic neuropathy: what's in the pipeline?
Akiyode, O., Lajthia, E., Unonu, J., Ketema, P., Olagundoye, Y.
Drugs Fut 2018, 43(5): 339
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Drugs Fut 2018, 43(5): 347
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 United States and Canadian Academy of Pathology (USCAP) - 107th Annual Meeting. Vancouver, BC, Canada – March 17-23, 2018.
Federico, M., Cole, P., Bofill, X.
Drugs Fut 2018, 43(5): 359
Summary | Full Text: PDF 
 
  
  
 American Chemical Society - 255th National Meeting and Exhibition. New Orleans, Louisiana, USA – March 18-22, 2018.
Font, H., Fernandez Forner, D.
Drugs Fut 2018, 43(5): 365
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences